US Regulatory Activity
In the United States, PFAS Management Remains a Priority for the Environmental Protection Agency (EPA) and Policymakers
On October 18, 2021, EPA Administrator Michael S. Regan announced the agency’s PFAS Strategic Roadmap. The Roadmap sets timelines by which EPA plans to take specific actions pertaining to per- and polyfluoroalkyl substances (PFAS) during the remaining first term of the Biden-Harris administration (2021-2024). It is focused on three central directives: (1) Research; (2) Restrict; and (3) Remediate. The Roadmap describes key actions within EPA’s program offices [Office of Chemical Safety and Pollution Prevention (OCSPP), Office of Water (OW), Office of Land and Emergency Management (OLEM), Office of Air and Radiation (OAR) and Office of Research and Development (ORD)] and cross-program initiatives.
For more information on the PFAS Strategic Roadmap visit the EPA site here https://www.epa.gov/pfas
EPA published a National Testing Strategy simultaneously with its release of the PFAS Strategic Roadmap.
The National Testing Strategy describes how EPA identified PFAS in 24 categories. The Agency will require companies to perform testing under Section 4 of the Toxic Substances Control Act (TSCA) on candidate substances representing the 24 categories. The Testing Strategy also describes a tiered-testing approach for each candidate PFAS that will inform whether additional testing within a category is necessary. EPA will implement the strategy in phases with Phase IA focused on human health data and Phase II on ecological toxicity.
For more information on the National PFAS Testing Strategy visit the EPA site here https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/national-pfas-testing-strategy